|
|
Volumn 13, Issue 2, 2002, Pages 251-257
|
|
Chemotherapy versus hormonal treatment in platinum- and paclitaxel-refractory ovarian cancer: A randomised trial of the German arbeitsgemeinschaft gynaekologische onkologie (AGO) study group ovarian cancer
a,b
h
Eye Hospital
(Germany)
|
|
Author keywords
Chemotherapy; Hormonal treatment; Ovarian cancer; Relapse; Second line therapy
|
|
Indexed keywords
CA 125 ANTIGEN;
CARBOPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
ETOPOSIDE;
FLUOROURACIL;
GEMCITABINE;
IDARUBICIN;
LEUPRORELIN;
MITOXANTRONE;
PACLITAXEL;
PLATINUM DERIVATIVE;
TAMOXIFEN;
TOPOTECAN;
TREOSULFAN;
ADULT;
AGED;
ANEMIA;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER GROWTH;
CANCER MORTALITY;
CANCER RECURRENCE;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG TOLERABILITY;
FEMALE;
FOLLOW UP;
GERMANY;
HORMONAL THERAPY;
HUMAN;
LIFESPAN;
MAJOR CLINICAL STUDY;
NAUSEA AND VOMITING;
NEUTROPENIA;
OVARY CANCER;
PATIENT SELECTION;
PRIORITY JOURNAL;
PROGNOSIS;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL TIME;
THROMBOCYTOPENIA;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BUSULFAN;
CISPLATIN;
FEMALE;
HUMANS;
LEUPROLIDE;
MIDDLE AGED;
OVARIAN NEOPLASMS;
PACLITAXEL;
SURVIVAL RATE;
|
|
EID: 0036299610
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1093/annonc/mdf038 Document Type: Article |
|
Times cited : (51)
|
|
References (29)
|
